Salarius Pharmaceuticals Inc.

07/13/2021 | Press release | Distributed by Public on 07/13/2021 08:59

Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas